{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T14:04:55Z","timestamp":1784642695955,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.3109\/14653249.2011.627916","type":"journal-article","created":{"date-parts":[[2011,11,22]],"date-time":"2011-11-22T04:50:38Z","timestamp":1321937438000},"page":"306-314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["A regenerative approach for bone repair in congenital pseudarthrosis of the tibia associated or not associated with type 1 neurofibromatosis: correlation between laboratory findings and clinical outcome"],"prefix":"10.1016","volume":"14","author":[{"given":"Donatella","family":"Granchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Devescovi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena Rubina","family":"Baglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Magnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onofrio","family":"Donzelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Baldini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3109\/14653249.2011.627916_bib0005","doi-asserted-by":"crossref","first-page":"228","DOI":"10.5435\/00124635-200804000-00006","article-title":"Congenital pseudarthrosis of the tibia","volume":"16","author":"Vander Have","year":"2008","journal-title":"J Am Acad Orthop Surg"},{"key":"10.3109\/14653249.2011.627916_bib0010","doi-asserted-by":"crossref","first-page":"346","DOI":"10.5435\/00124635-201006000-00007","article-title":"Orthopaedic manifestations of neurofibromatosis type 1","volume":"18","author":"Feldman","year":"2010","journal-title":"J Am Acad Orthop Surg"},{"key":"10.3109\/14653249.2011.627916_bib0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/01202412-200001000-00003","article-title":"Congenital pseudarthrosis of the tibia: history, etiology, classification, and epidemiologic data","volume":"9","author":"Hefti","year":"2000","journal-title":"J Pediatr Orthop B"},{"key":"10.3109\/14653249.2011.627916_bib0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01.bpo.0000151054.54732.0b","article-title":"Treatment of congenital pseudarthrosis of the tibia: a multicenter study in Japan","volume":"25","author":"Ohnishi","year":"2005","journal-title":"J Pediatr Orthop"},{"key":"10.3109\/14653249.2011.627916_bib0025","first-page":"57","article-title":"A retrospective review of congenital pseudarthrosis of the tibia","volume":"22","author":"Carney","year":"2002","journal-title":"Iowa Orthop J"},{"key":"10.3109\/14653249.2011.627916_bib0030","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.3109\/14653249.2011.627916_bib0035","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.semcdb.2007.09.012","article-title":"Therapeutic applications of mesenchymal stromal cells","volume":"18","author":"Brooke","year":"2007","journal-title":"Semin Cell Dev Biol"},{"issue":"S1","key":"10.3109\/14653249.2011.627916_bib0040","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2106\/JBJS.G.01521","article-title":"Critical analysis of the evidence for current technologies in bone-healing and repair","volume":"90","author":"Novicoff","year":"2008","journal-title":"J Bone Joint Surg Am"},{"issue":"S1","key":"10.3109\/14653249.2011.627916_bib0045","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2106\/00004623-200609001-00015","article-title":"Percutaneous autologous bone-marrow grafting for nonunions. Surgical technique","volume":"88","author":"Hernigou","year":"2006","journal-title":"J Bone Joint Surg Am"},{"key":"10.3109\/14653249.2011.627916_bib0050","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1302\/0301-620X.77B5.7559719","article-title":"Percutaneous autogenous bone-marrow grafting in congenital tibial pseudarthrosis","volume":"77","author":"Garg","year":"1995","journal-title":"J Bone Joint Surg Br"},{"key":"10.3109\/14653249.2011.627916_bib0055","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.bone.2004.06.013","article-title":"Transplantation of marrow-derived mesenchymal stem cells and platelet-rich plasma during distraction osteogenesis: a preliminary result of three cases","volume":"35","author":"Kitoh","year":"2004","journal-title":"Bone"},{"key":"10.3109\/14653249.2011.627916_bib0060","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/bpo.0b013e31815a6058","article-title":"Proximal tibial lengthening by distraction osteogenesis in congenital pseudarthrosis of the tibia","volume":"27","author":"Cho","year":"2007","journal-title":"J Pediatr Orthop"},{"key":"10.3109\/14653249.2011.627916_bib0065","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3109\/14653249.2010.487898","article-title":"Attempt to treat congenital pseudarthrosis of the tibia with mesenchymal stromal cell transplantation","volume":"12","author":"Tikkanen","year":"2010","journal-title":"Cytotherapy"},{"key":"10.3109\/14653249.2011.627916_bib0070","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bone.2008.10.050","article-title":"Congenital pseudarthrosis of neurofibromatosis type 1: impaired osteoblast differentiation and function and altered NF1 gene expression","volume":"44","author":"Leskel\u00e4","year":"2009","journal-title":"Bone"},{"key":"10.3109\/14653249.2011.627916_bib0075","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.bone.2009.10.044","article-title":"Biological basis for the use of autologous bone marrow stromal cells in the treatment of congenital pseudarthrosis of the tibia","volume":"46","author":"Granchi","year":"2010","journal-title":"Bone"},{"key":"10.3109\/14653249.2011.627916_bib0080","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/hmg\/ddm032","article-title":"Multiple roles for neurofibromin in skeletal development and growth","volume":"16","author":"Kolanczyk","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.3109\/14653249.2011.627916_bib0085","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bone.2007.11.006","article-title":"Recent insights into bone development, homeostasis, and repair in type 1 neurofibromatosis (NF1)","volume":"42","author":"Schindeler","year":"2008","journal-title":"Bone"},{"key":"10.3109\/14653249.2011.627916_bib0090","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1359\/JBMR.040130","article-title":"NF1 tumor suppressor protein and mRNA in skeletal tissues of developing and adult normal mouse and NF1-deficient embryos","volume":"19","author":"Kuorilehto","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.3109\/14653249.2011.627916_bib0095","unstructured":"Neurofibromatosis. NIH Consens Statement Online 1987 Jul 13\u201315;6(12):1\u201319.http:\/\/consensus.nih.gov\/1987\/1987Neurofibramatosis064html.htm 09\/10\/2009."},{"key":"10.3109\/14653249.2011.627916_bib0100","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tibtech.2008.11.009","article-title":"Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF)","volume":"27","author":"Dohan Ehrenfest","year":"2009","journal-title":"Trends Biotechnol"},{"key":"10.3109\/14653249.2011.627916_bib0105","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/jbm.b.30375","article-title":"Evaluation of bone healing enhancement by lyophilized bone grafts supplemented with platelet gel: a standardized methodology in patients with tibial osteotomy for genu varus","volume":"76","author":"Savarino","year":"2006","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"10.3109\/14653249.2011.627916_bib0110","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2106\/00004623-195638020-00004","article-title":"Congenital pseudarthrosis of the tibia treated by intramedullary nail","volume":"38","author":"Charnley","year":"1956","journal-title":"J Bone Joint Surg Am"},{"key":"10.3109\/14653249.2011.627916_bib0115","doi-asserted-by":"crossref","first-page":"6150","DOI":"10.1016\/j.biomaterials.2006.08.025","article-title":"Human bone marrow stromal cells: in vitro expansion and differentiation for bone engineering","volume":"27","author":"Ciapetti","year":"2006","journal-title":"Biomaterials"},{"key":"10.3109\/14653249.2011.627916_bib0120","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/ijc.23654","article-title":"Paracrine inhibition of osteoblast differentiation induced by neuroblastoma cells","volume":"123","author":"Granchi","year":"2008","journal-title":"Int J Cancer"},{"key":"10.3109\/14653249.2011.627916_bib0125","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/ten.tec.2009.0405","article-title":"Gene expression patterns related to osteogenic differentiation of bone marrow-derived mesenchymal stem cells during ex vivo expansion","volume":"16","author":"Granchi","year":"2010","journal-title":"Tissue Eng Part C Methods"},{"key":"10.3109\/14653249.2011.627916_bib0130","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nmeth0405-313","article-title":"ProbeLibrary: a new method for faster design and execution of quantitative real-time PCR","volume":"4","author":"Mouritzen","year":"2005","journal-title":"Nat Methods"},{"key":"10.3109\/14653249.2011.627916_bib0135","first-page":"33","article-title":"Bone marrow in patients with pseudarthrosis. A study of progenitor cells by in vitro cloning","volume":"83","author":"Hernigou","year":"1997","journal-title":"Rev Chir Orthop Reparatrice Appar Mot"},{"key":"10.3109\/14653249.2011.627916_bib0140","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s00223-007-9020-6","article-title":"Number and proliferative capacity of human mesenchymal stem cells are modulated positively in multiple trauma patients and negatively in atrophic nonunions","volume":"80","author":"Seebach","year":"2007","journal-title":"Calcif Tissue Int"},{"key":"10.3109\/14653249.2011.627916_bib0145","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.bone.2008.01.013","article-title":"Cell viability, osteoblast differentiation, and gene expression are altered in human osteoblasts from hypertrophic fracture non-unions","volume":"42","author":"Hofmann","year":"2008","journal-title":"Bone"},{"key":"10.3109\/14653249.2011.627916_bib0150","first-page":"1","article-title":"Bone morphogenetic protein (BMP) for fracture healing in adults","volume":"6","author":"Garrison","year":"2010","journal-title":"The Cochran Library"},{"key":"10.3109\/14653249.2011.627916_bib0155","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/01.bpb.0000194439.75378.ac","article-title":"Treatment of a congenital pseudarthrosis of the tibia by osteogenic protein-1 (bone morphogenetic protein-7): a case report","volume":"15","author":"Anticevic","year":"2006","journal-title":"J Pediatr Orthop B"},{"key":"10.3109\/14653249.2011.627916_bib0160","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1302\/0301-620X.88B1.16619","article-title":"Bone morphogenetic protein 7 in the treatment of congenital pseudarthrosis of the tibia","volume":"88","author":"Fabeck","year":"2006","journal-title":"J Bone Joint Surg Br"},{"key":"10.3109\/14653249.2011.627916_bib0165","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2106\/00004623-200603000-00023","article-title":"Treatment of congenital pseudarthrosis of the tibia with recombinant human bone morphogenetic protein-7 (rhBMP-7). A report of five cases","volume":"88","author":"Lee","year":"2006","journal-title":"J Bone Joint Surg Am"},{"key":"10.3109\/14653249.2011.627916_bib0170","first-page":"132","article-title":"Treatment of congenital pseudarthrosis of the tibia with native bovine BMP: a case report","volume":"74","author":"Kujala","year":"2008","journal-title":"Acta Orthop Belg"},{"key":"10.3109\/14653249.2011.627916_bib0175","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2106\/JBJS.H.01667","article-title":"The use of rhBMP-2 for the treatment of congenital pseudarthrosis of the tibia: a case series","volume":"92","author":"Richards","year":"2010","journal-title":"J Bone Joint Surg Am"},{"key":"10.3109\/14653249.2011.627916_bib0180","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/PRS.0b013e318205f2b4","article-title":"Recombinant human bone morphogenetic protein-2-induced craniosynostosis and growth restriction in the immature skeleton","volume":"127","author":"Kinsella","year":"2011","journal-title":"Plast Reconstr Surg"},{"key":"10.3109\/14653249.2011.627916_bib0185","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/BPO.0b013e3181d075ab","article-title":"Complications associated with the use of bone morphogenetic protein in pediatric patients","volume":"30","author":"Oetgen","year":"2010","journal-title":"J Pediatr Orthop"},{"key":"10.3109\/14653249.2011.627916_bib0190","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.fcl.2005.06.009","article-title":"The role of platelet-rich plasma in foot and ankle surgery","volume":"10","author":"Gandhi","year":"2005","journal-title":"Foot Ankle Clin"},{"key":"10.3109\/14653249.2011.627916_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12306-009-0048-9","article-title":"Background and rationale of platelet gel in orthopaedic surgery","volume":"94","author":"Cenni","year":"2010","journal-title":"Musculoskelet Surg"},{"key":"10.3109\/14653249.2011.627916_bib0200","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1582-4934.2010.01224.x","article-title":"Bone regeneration and stem cells","volume":"15","author":"Arvidson","year":"2011","journal-title":"J Cell Mol Med"},{"key":"10.3109\/14653249.2011.627916_bib0205","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.injury.2008.06.025","article-title":"The clinical use of platelet-rich plasma in the promotion of bone healing: a systematic review","volume":"40","author":"Griffin","year":"2009","journal-title":"Injury"},{"key":"10.3109\/14653249.2011.627916_bib0210","first-page":"96","article-title":"Lights and shadows concerning platelet products for musculoskeletal regeneration","volume":"3","author":"Tschon","year":"2011","journal-title":"Front Biosci (Elite Ed)"},{"key":"10.3109\/14653249.2011.627916_bib0215","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1089\/ten.tea.2009.0254","article-title":"Growth factor-rich plasma increases tendon cell proliferation and matrix synthesis on a synthetic scaffold: an in vitro study","volume":"16","author":"Visser","year":"2010","journal-title":"Tissue Eng Part A"},{"key":"10.3109\/14653249.2011.627916_bib0220","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.2741\/2296","article-title":"Signaling and transcriptional regulation in osteoblast commitment and differentiation","volume":"2","author":"Huang","year":"2007","journal-title":"Front Biosci"},{"key":"10.3109\/14653249.2011.627916_bib0225","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-0765.2007.01014.x","article-title":"Bone sialoprotein and its transcriptional regulatory mechanism","volume":"43","author":"Ogata","year":"2008","journal-title":"J Periodontal Res"},{"key":"10.3109\/14653249.2011.627916_bib0230","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S1357-2725(99)00090-4","article-title":"SPARC (osteonectin\/BM-40)","volume":"31","author":"Motamed","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"key":"10.3109\/14653249.2011.627916_bib0235","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1177\/088307380201700807","article-title":"Antiangiogenesis in neurofibromatosis 1","volume":"17","author":"Kurtz","year":"2002","journal-title":"J Child Neurol"},{"key":"10.3109\/14653249.2011.627916_bib0240","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1034\/j.1600-0625.2003.00062.x","article-title":"Expression of angiogenic factors in neurofibromas","volume":"12","author":"Kawachi","year":"2003","journal-title":"Exp Dermatol"},{"key":"10.3109\/14653249.2011.627916_bib0245","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/sj.onc.1204026","article-title":"The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells","volume":"20","author":"Mashour","year":"2001","journal-title":"Oncogene"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324912706424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324912706424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:16:29Z","timestamp":1761430589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324912706424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S1465324912706424"],"URL":"https:\/\/doi.org\/10.3109\/14653249.2011.627916","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A regenerative approach for bone repair in congenital pseudarthrosis of the tibia associated or not associated with type 1 neurofibromatosis: correlation between laboratory findings and clinical outcome","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3109\/14653249.2011.627916","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}